Atlas Trials

A Study That Compares the Extent to Which Apomorphine Becomes Available in the Body After Taking Either an Investigational Drug Containing Apomorphine or Apomorphine That is Injected Under the Skin in People With PD Complicated by "OFF" Episodes

Clinical trial NCT03292016 · COMPLETED

Trial details

NCT number
NCT03292016
Sponsor
Sumitomo Pharma America, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Parkinson Disease
Start date
2017-08-22
Primary completion
2019-03-05
Enrollment
8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.